HR 762 106th Congress House Health Access to health care Ambulatory care Autoimmune diseases Black women Case management Clinical trials Commerce Consumer education Department of Health and Human Services Diseases Economics and Public Finance Education Epidemiology Federal aid to health facilities Federal aid to medical education Federal aid to medical research Government Operations and Politics Health education Health insurance continuation

Lupus Research and Care Amendments of 2000

Introduced: February 12, 1999 See on congress.gov

Everywhere this bill has been 18 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Oct 11, 2000

Received in the Senate.

Oct 10, 2000

Motion to reconsider laid on the table Agreed to without objection.

Oct 10, 2000

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 385 - 2 (Roll no. 521). (text: CR H9532)

Oct 10, 2000

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 385 - 2 (Roll no. 521).(text: CR H9532)

Oct 10, 2000

Considered as unfinished business. (consideration: CR H9574-9575)

Oct 10, 2000

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Oct 10, 2000

DEBATE - The House proceeded with forty minutes of debate on H.R. 762.

Oct 10, 2000

Considered under suspension of the rules. (consideration: CR H9532-9535)

Oct 10, 2000

Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.

Oct 10, 2000

Placed on the Union Calendar, Calendar No. 570.

Oct 10, 2000

Reported (Amended) by the Committee on Commerce. H. Rept. 106-950.

Sep 26, 2000

Ordered to be Reported (Amended) by Voice Vote.

Sep 26, 2000

Committee Consideration and Mark-up Session Held.

Sep 26, 2000

Subcommittee on Health and Environment Discharged.

Jul 12, 1999

Sponsor introductory remarks on measure. (CR E1513-1514)

Mar 1, 1999

Referred to the Subcommittee on Health and Environment.

Feb 12, 1999

Referred to the House Committee on Commerce.

Feb 12, 1999

Introduced in House

Votes taken on this bill 1

Date	Chamber	What was voted on	Result	Yes–No
Oct 10, 2000	House · vote #521	Motion to Suspend the Rules and Pass, as Amended	Passed	385–2	See who voted →

Plain-English summary Congressional Research Service

Lupus Research and Care Amendments of 2000 - Title I: Research on Lupus - Amends the Public Health Service Act to require the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to expand and intensify research and related activities of the Institute regarding lupus.

Requires the Director to: (1) coordinate such activities with similar activities conducted by other national research institutes and agencies of the National Institutes of Health; and (2) conduct or support research to expand the understanding of the causes of, and to find a cure for, lupus, including research to determine the reasons underlying the elevated prevalence of the disease among African-American and other women.

Authorizes appropriations.

Title II: Delivery of Services Regarding Lupus - Mandates grants for the establishment, operation, and coordination of effective and cost-efficient systems for the delivery of essential services to individuals with lupus and their families. Requires the Secretary of Health and Human Services to: (1) ensure that grant projects provide services for lupus diagnosis and disease management; and (2) integrate such projects with other grant programs carried out by the Secretary. Authorizes technical assistance. Authorizes appropriations.

What's happening now October 11, 2000

Received in the Senate.

Committees of jurisdiction 2

Energy and Commerce Committee
House of Representatives
Health and Environment Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee

Cosponsors 28